CN111500531A - Method for in vitro long-term culture of chicken PGCs - Google Patents

Method for in vitro long-term culture of chicken PGCs Download PDF

Info

Publication number
CN111500531A
CN111500531A CN202010410510.1A CN202010410510A CN111500531A CN 111500531 A CN111500531 A CN 111500531A CN 202010410510 A CN202010410510 A CN 202010410510A CN 111500531 A CN111500531 A CN 111500531A
Authority
CN
China
Prior art keywords
pgcs
cells
cultured
culture
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010410510.1A
Other languages
Chinese (zh)
Inventor
杨婷
常国斌
仇玲玲
陈博雯
孔令琳
白蒙
董钊绮
胡晓丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yangzhou University
Original Assignee
Yangzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yangzhou University filed Critical Yangzhou University
Priority to CN202010410510.1A priority Critical patent/CN111500531A/en
Publication of CN111500531A publication Critical patent/CN111500531A/en
Priority to AU2021101223A priority patent/AU2021101223A4/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0608Germ cells
    • C12N5/0609Oocytes, oogonia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0604Whole embryos; Culture medium therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0608Germ cells
    • C12N5/061Sperm cells, spermatogonia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/40Nucleotides, nucleosides or bases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/44Thiols, e.g. mercaptoethanol
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/115Basic fibroblast growth factor (bFGF, FGF-2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/125Stem cell factor [SCF], c-kit ligand [KL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/235Leukemia inhibitory factor [LIF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/02Coculture with; Conditioned medium produced by embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method for culturing chicken PGCs in vitro for a long time includes such steps as separating chicken PGCs, purifying and culturing the PGCs, systematically comparing the addition of feeder layer, the treatment of feeder layer and the addition ratio of BR L to culture medium, and culturing chicken PGCs in vitro for a long time.

Description

Method for in vitro long-term culture of chicken PGCs
Technical Field
The invention relates to a method for in vitro long-term culture of chicken PGCs, belonging to the technical field of zootechnics and cytology.
Background
Since Dubois reported in 1969, several studies have been conducted on chicken PGCs, and several basic growth factors and specific growth factors L IF, bFGF and hSCF have been found to maintain PGC survival, proliferation and growth in vitro, and in addition, in combination with growth factors, conditioned medium and feeder cells, PGC can remain proliferative and undifferentiated in vitro for long periods of time, but there are few available methods for long-term culture of PGCs in vitro, which greatly affects long-term studies and utilization of PGC.
Disclosure of Invention
Although many research researches on separation methods, in vitro culture and the like of chicken PGCs are carried out, no systematic and comprehensive culture system is available for in vitro long-term culture of PGCs, which greatly limits research and application of poultry PGCs in aspects of germ cell development, genetic resource protection and the like.
Therefore, the invention provides a method for in vitro long-term culture of chicken PGCs, and the compound culture system can be used for carrying out long-term in vitro culture on PGCs, so that research and application of poultry PGCs in the aspects of germ cell development, genetic resource protection and the like can be fully carried out.
In order to achieve the purpose of the invention, the technical scheme adopted by the invention is as follows:
the chicken PGCs are obtained by separation, and then the PGCs are purified and cultured, systematic comparison is made on the aspects of the PGC culture method, whether a feeding layer is added or not, the feeding layer treatment method, the addition proportion of a BR L conditioned medium and the like, and finally the method for in-vitro long-term culture of the chicken PGCs is determined.
Specifically, the method comprises the following steps:
separating chicken PGCs from gonads of 4.5-5.5 d embryo chicken embryos, and purifying the PGCs by a differential wall-pasting method. The culture methods of PGCs were systematically compared in terms of whether or not a feeder layer was added, the method of treating the feeder layer, the ratio of the addition of the conditioned medium, and the like.
The results showed that PGCs were cultured for about 300 days on feeder cells treated with 20. mu.g/ml mitomycin C for 2 hours and in a complex culture system in factor medium supplemented with 50% BR L conditioned medium, and that PGCs cultured for a long period in this culture system maintained high proliferative capacity without transformation, and their pluripotency, migratory ability and differentiative ability.
The invention has the following beneficial effects:
the method for culturing chicken PGCs in vitro for a long term is obtained through experiments such as respectively treating the feeder layer cells with mitomycin C with various concentrations (10, 15, 20 and 30 mug/ml) for different times (2, 3 and 4h) according to the addition of the feeder layer cells, adding BR L conditioned medium with different proportions (0%, 20%, 40%, 50%, 60% and 80%) into the culture medium, and the like.
In order to fully exert the value of PGC used as a transgenic tool and a bioreactor carrier and simultaneously more conveniently and effectively utilize the chicken gonad PGC, the invention researches the optimal culture system for culturing the chicken gonad PGC for a long time, thereby fully excavating the research value of the chicken gonad PGC and laying a solid foundation for later-stage PGC establishment and even production of transgenic chickens.
Drawings
FIG. 1 is a schematic diagram showing the isolation and culture of PGCs in the present invention;
in the figure: A-D are morphologies of the cultured PGCs;
a is that PGCs are separated at the 27 th embryonic stage (C arrow), and are subjected to primary culture together with chick embryo gonad stromal cells (B arrow) and blood cells (A arrow);
b is PGC aggregation for 3 days of primary culture (C arrow);
c is the growth of PGCs which are difficult to maintain by gonadal stromal cells after 7 days of primary culture (C arrow);
d is subculture of PGCs on mitomycin C treated feeder cells (C arrow);
e is the morphology of STO cells;
f is the morphology of BR L cells;
FIG. 2 shows a complex culture system for PGCs;
in the figure: a is the form of PGC with feeder cells and the form of PGC 5 days after no addition of bFGF;
b is the cell proliferation rate of PGC with feeder cells and 5 days after the addition of bFGF;
c is that when the cell fusion degree reaches 60%, mitomycin C with various concentrations (10, 15, 20 and 30g/ml) is respectively used for treating feeder layer cells for 2, 3 and 4 hours, and CCK-8 is used for detecting the influence of the mitomycin C treatment on cell proliferation and vitality;
d is the growth curve of STO cells treated with mitomycin C at different concentrations;
e morphology of mitomycin C treated STO cells at different concentrations;
f is the cell proliferation rate of PGCs supplemented with BR L Conditioned Medium (CM) and 5 days later without BR L conditioned medium;
g is a conditioned medium which is added into the culture medium in a proportion of 0%, 20%, 40%, 50%, 60% and 80%, and the proliferation rate and the activity of the PGCs are detected by CCK-8;
FIG. 3 shows that PGC cell lines maintain high proliferation potency without transformation
In the figure: a is a growth curve of PGCs separately cultured by the culture system;
b is ZW type chicken PGCs (female parent) metaphase (left) chromosome and karyotype (right), and the chromosome karyotype is still diploid;
C-E cell cycle analysis of freshly isolated PGCs (C), thawed PGCs (D), and long-term cultured PGCs (E);
f is the colony forming ability of PGCs; colony forming ability of hela cells (positive control) (top) and PGCs (bottom) at 1, 3, 5, 7 days was measured by soft agar method;
g is the number of clones measured by the soft agar method under a stereomicroscope after crystal violet staining;
h is RT-PCR analysis of telomerase reverse transcriptase in PGCs cultured in vitro (cultured for 15, 68, 180 and 268 days and thawed PGCs);
FIG. 4 shows that PGCs cultured for a long period of time have high pluripotency and differentiation potential;
in the figure, A-D are immunocytochemical analyses of cultured PGCs, and 180 days after the culture, immunohistochemical staining was performed with antibodies against SSEA-1(A), C-kit (B), cDAZ L (C) and Sox2(D), respectively
E is RT-PCR analysis of in vitro cultured PGCs (cultured for 15, 68, 180, 268 days and thawed) POUV, NANOG, DAZ L;
f is migration of the cultured PGCs to the crescent area of the reproductive system; approximately 3000 PGCs cultured for 200 days were labeled with PKH26 and then transferred to the subgerminal cavity of embryonic blastoderms; labeled cells (red) were detected in the crescentic region of reproduction;
g is gonad migration of the cultured PGCs; PKH 26-labeled PGCs on the left, and controls on the right; approximately 3000 PGCs cultured for 230 days were labeled with PKH26 and then injected into the blood vessels of recipient embryos at stages 14-17; detection of labeled cells in the embryonic gonads (red);
h isolating cells from gonads of PGCs labeled with PKH 26;
i is the formation of Embryoid Bodies (EB) of PGCs cultured for 248 days, and 2 mu mol/L of RA is used to induce PGCs cultured for a long time, and after 7 days, simple embryoid bodies (upper) grow and can continue to grow for 14 days (lower).
Detailed Description
A method for in vitro long-term culture of chicken PGCs comprises the following specific steps:
1. materials and methods
1.1 isolation, purification and culture of PGCs
Fertilized eggs (Babcock B300 strain; Yangzhou Rui agricultural technologies, Inc.) were incubated at 37 ℃ and 70% relative humidity. After 120H incubation, gonadal tissue was extracted from embryos at about H & H27 stage under a stereomicroscope with fine forceps, PGCs were isolated by enzymatic digestion, and cells were further purified by differential adherence.
PGCs were placed on a feeder layer of mitomycin C-treated STO and cultured in an incubator at 37 ℃ with 5% CO2 and 60-70% relative humidity, the medium consisted of KO-DMEM, and 10% Fetal Bovine Serum (FBS), 2.5% Chicken Serum (CS), 2mM L-glutamine, 1 × MEM nonessential amino acids, 1 × nucleosides, 1 × HEPES, 0.1mM β -mercaptoethanol, 5ng/ml human stem cell factor (hSCF), 10ng/ml basic fibroblast growth factor (bFGF) and 10ng/ml mouse leukemia inhibitory factor (L IF) were added to the medium.
1.2 treatment of feeder layers
In the incubator, STO was cultured in DMEM medium containing 10% FBS. To determine the optimal concentration for feeder cells, we treated STO 2, STO 3, and STO 4h with mitomycin C at various concentrations (10, 15, 20, and 30. mu.g/ml) after 60% confluence, and then examined cell viability using CCK-8 assay. To prevent excessive toxicity of mitomycin C, STO was subcultured on complete medium for at least 24h, after which the inactivated STO was used as a feeder layer for PGC.
1.3 preparation of conditioned Medium
BR L was cultured in KO-DMEM medium containing 10% FBS, 2mM L-glutamine, the medium was changed within 24h to remove debris and waste from the cells after passaging, conditioned medium was collected, filtered, and then added to PGC medium after 2 days of medium change, and to test the optimum addition ratio of BR L conditioned medium, we then added 0%, 20%, 40%, 50%, 60%, 80% conditioned medium, respectively, and tested the viability of the cultured PGCs with CCK-8.
1.4 cryopreservation and thawing of PGCs
The cultured PGCs were collected and resuspended in cryoprotectant containing 10% DMSO and 90% FBS, each tube was frozen 2 × 106-1×107The individual cell cryovials were placed in a freezing container with isopropanol and stored overnight in a freezer at-80 ℃. The sample in the cryovial was heated in a water bath at 37 ℃ and then shaken until the ice crystals disappeared. The antifreeze was diluted 10-fold in 1 minute.
1.5 cell viability assay
To measure cell viability, cell counting kit 8(CCK-8) was used according to the instructions, cells were seeded into 96-well plates, after approximately 24h of culture, treated according to the instructions CCK-8(10 μ l) was added per well, incubated for 1.5 hours, and then cell viability was measured, absorbance was measured at 450nm with a Microplate reader, cell viability was calculated according to the formula (control OD-treated OD)/(control OD-blank OD) × 100%, assay was repeated 3 times.
1.6 immunofluorescence
Cultured PGCs were seeded into 24-well plates with treated feeder layers and incubated for about 24 h.cells were fixed in freshly prepared 4% paraformaldehyde-PBS for 20min, then washed 3 times with Phosphate Buffered Saline (PBS), then samples were treated with 0.5% Triton X-100 permeabilization buffer for 20min after 3 washes with PBS, cells were blocked with 1% bovine serum albumin blocking buffer for 30min, then incubated with primary antibody (anti-SSEA-1, c-kit, Sox2, cDAZ L) diluted to 5-20 μ g/m L in BSA at 4 ℃ overnight protected from light, after 3 washes with PBS containing 0.05% Tween-20 (PBS-T), cells were incubated with secondary antibody conjugated with fluorescent dye for 1h at room temperature, finally cells were counterstained with DAPI for 10min and analyzed under fluorescent microscope.
1.7 cell cycle analysis
To analyze cell cycle and apoptosis of freshly isolated PGCs, thawed PGCs and long-term cultured PGCs, a cell cycle and apoptosis assay kit (Beyotime) was used according to the instructions. Harvested cells were fixed with 70% ethanol overnight and then incubated with RNase for 5 min. After addition of Propidium Iodide (PI) at 37 ℃ away from light for 30min, the DNA content was analyzed using a FACSCalibur flow cytometer over 24 h.
1.8 Soft agar assay
1.2% melted agar was cooled to 37 ℃ and mixed with 2 × DMEM containing 20% fetal bovine serum as the basal layer, the final concentration of agarose being 0.6%. cells suspended in 0.3% agarose (1000 cells/m L) were then seeded onto the basal layer (an appropriate amount of medium was added to keep moist). 7d the colony formation was observed under a microscope, and the visible colonies were stained with crystal violet and counted under a stereomicroscope.
1.9RT-PCR analysis
Total RNA of the cultured PGCs was extracted using RNeasy Mini Kit (Qiagen, Valencia, CA) (cultured for 15, 68, 180 and 268 days and thawed), and the First Strand cDNA library was reverse transcribed using Transcriptor First-Strand cDNA Synthesis and the target cDNA was amplified by RT-PCR. The reaction involved 35 cycles (95 20s, 60 ℃ 40s, 72 1 min). GAPDH expression was used as a reference to normalize expression levels.
1.10 karyotyping
The cultured PGC was mixed with colchicine (final concentration 0.25. mu.g/ml) at 37 ℃ in 5% CO2After 4h, the cells were harvested, centrifuged and resuspended in 0.075M KCl preheated to 37 ℃. After incubation at 37 ℃ for 15min, the cells were pelleted again, and the cells were incubated with 3: 1 methanol: fix with acetic acid and wash 3 times with fixative. Finally, the cell suspension was dropped onto a cooled glass slide and stained with Giemsa.
1.11 gonadal migration test
Long-term cultured PGCs were used for migration assays. To determine the migration of PGCs into the crescentic region of reproduction, cells were labeled with PKH26 red fluorescent cell linker minikit (Sigma), 3000 cells per egg were transferred into the subgerminal cavity of the stage X recipient embryo. Incubation of the Parafilm-sealed recipient eggs was continued for 24h until stage 6, and the crescentic area of the in vitro embryos was observed under a fluorescent microscope. PKH 26-labeled PGCs were injected into the dorsal aorta of stage 14-17 embryos to analyze PGC migration to the gonads. It was sealed with Parafilm and incubated to stage 30 and the gonads were observed under a fluorescent microscope.
1.12RA Induction assay
PGCs cultured by induction with Retinoic Acid (RA) were differentiated into germ cells to test their differentiation ability, and the PGCs were cultured in a feeder-free complete medium containing 2. mu.M/M L RA, and their morphological changes were observed by an inverted microscope.
1.13 statistical analysis
All results are expressed as mean values. Statistical analysis and graphical representation were performed using GraphPad Prism 6 software. P values less than 0.05 were considered significant, and P values less than 0.01 were considered very significant.
As can be seen from FIGS. 1 and 2, the chicken PGCs were cultured in vitro for a long period in a complex culture system of STO feeder cells treated with mitomycin C at 20. mu.g/ml for 2 hours and factor medium supplemented with 50% BR L conditioned medium.
As can be seen from FIGS. 3 and 4, PGCs cultured in vitro for a long period of time still have high proliferative capacity without transformation, and still have high pluripotency and differentiation capacity.

Claims (5)

1. A method for long-term in vitro culture of chicken PGCs is characterized in that chicken PGCs are obtained by separation, and then the PGCs are purified and cultured; as for the culture of PGCs, the feeder layer is treated and a conditioned medium is added, and PGCs can be cultured in the complex culture system for a long period of time, maintain high proliferation ability without transformation, and maintain pluripotency, migration ability and differentiation ability.
2. The method of claim 1, wherein the step of isolating and purifying the PGCs comprises:
incubating the fertilized egg at 37 ℃ and 70% relative humidity; after 120H incubation, gonadal tissue was extracted from H & H27 stage embryos using fine forceps under a stereomicroscope, PGCs were isolated by enzymatic digestion, and cells were further purified by differential adherence.
3. The method of claim 2, wherein the culturing of the PGCs comprises:
placing PGCs on a feeder layer of mitomycin C-treated STO, and culturing in an incubator at 37 deg.C, 5% CO2, and 60-70% relative humidity;
the culture medium is composed of KO-DMEM, and 10% fetal calf serum, 2.5% chicken serum, 2mM L-glutamine, 1 × MEM nonessential amino acids, 1 × nucleosides, 1 × HEPES, 0.1mM β -mercaptoethanol, 5ng/ml human stem cell factor, 10ng/ml basic fibroblast growth factor and 10ng/ml mouse leukemia inhibitory factor are added into the culture medium;
in subculture, the medium in which the PGCs were cultured was changed every day, and the cells were dissociated with Accutase and passaged onto newly treated feeder cells.
4. The method of claim 3, wherein the feeder layer is treated by: feeder cells were treated with 20. mu.g/ml mitomycin C for 2 h.
5. The method of claim 4, wherein the ratio of BR L conditioned medium to total medium is 50% BR L conditioned medium.
CN202010410510.1A 2020-05-15 2020-05-15 Method for in vitro long-term culture of chicken PGCs Pending CN111500531A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202010410510.1A CN111500531A (en) 2020-05-15 2020-05-15 Method for in vitro long-term culture of chicken PGCs
AU2021101223A AU2021101223A4 (en) 2020-05-15 2021-03-09 METHOD FOR LONG-TERM IN VITRO CULTURE OF CHICKEN PGCs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010410510.1A CN111500531A (en) 2020-05-15 2020-05-15 Method for in vitro long-term culture of chicken PGCs

Publications (1)

Publication Number Publication Date
CN111500531A true CN111500531A (en) 2020-08-07

Family

ID=71873345

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010410510.1A Pending CN111500531A (en) 2020-05-15 2020-05-15 Method for in vitro long-term culture of chicken PGCs

Country Status (2)

Country Link
CN (1) CN111500531A (en)
AU (1) AU2021101223A4 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114410572A (en) * 2022-01-24 2022-04-29 成都思澍生物科技有限公司 Method for quickly separating high-purity primordial germ cells from chick embryo blood
CN115088679A (en) * 2022-07-20 2022-09-23 扬州大学 Method for constructing chimera chicken breed conservation by utilizing gonad cells
CN116855444A (en) * 2023-07-06 2023-10-10 扬州大学 Method for establishing chicken primordial germ cell monoclonal cell line

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006533A1 (en) * 1997-08-04 1999-02-11 University Of Massachusetts A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof
WO2000008132A1 (en) * 1998-08-03 2000-02-17 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Prolonged culturing of avian primordial germ cells using specific growth factors and use thereof
WO2000047717A1 (en) * 1999-02-11 2000-08-17 Hanmi Pharm. Co., Ltd. Avian pluripotent embryonic germ cell line
WO2001011019A1 (en) * 1999-08-09 2001-02-15 North Carolina State University Method of producing an undifferentiated avian cell culture using avian primordial germ cells
US20060174362A1 (en) * 2005-02-01 2006-08-03 Origen Therapeutics, Inc. Long-term culture of avian primordial germ cells (PGCs)
CN1821389A (en) * 2006-03-02 2006-08-23 扬州大学 External Cultivating method for bird primordial germ cell
CN101504339A (en) * 2009-02-24 2009-08-12 扬州大学 Method for detecting early archaeocyte of quail
CN103827293A (en) * 2011-06-29 2014-05-28 通用医疗公司 Compositions and methods for enhancing bioenergetic status in female germ cells
WO2016091272A1 (en) * 2014-12-12 2016-06-16 Central Veterinary Research Laboratory System and method for establishing a long-term culture of avian primordial germ cells and uses thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006533A1 (en) * 1997-08-04 1999-02-11 University Of Massachusetts A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof
WO2000008132A1 (en) * 1998-08-03 2000-02-17 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Prolonged culturing of avian primordial germ cells using specific growth factors and use thereof
WO2000047717A1 (en) * 1999-02-11 2000-08-17 Hanmi Pharm. Co., Ltd. Avian pluripotent embryonic germ cell line
WO2001011019A1 (en) * 1999-08-09 2001-02-15 North Carolina State University Method of producing an undifferentiated avian cell culture using avian primordial germ cells
US20060174362A1 (en) * 2005-02-01 2006-08-03 Origen Therapeutics, Inc. Long-term culture of avian primordial germ cells (PGCs)
CN1821389A (en) * 2006-03-02 2006-08-23 扬州大学 External Cultivating method for bird primordial germ cell
CN101504339A (en) * 2009-02-24 2009-08-12 扬州大学 Method for detecting early archaeocyte of quail
CN103827293A (en) * 2011-06-29 2014-05-28 通用医疗公司 Compositions and methods for enhancing bioenergetic status in female germ cells
WO2016091272A1 (en) * 2014-12-12 2016-06-16 Central Veterinary Research Laboratory System and method for establishing a long-term culture of avian primordial germ cells and uses thereof

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
KONG LL等: "Long-term in vitro culture and preliminary establishment of chicken primordial germ cell lines", 《PLOS ONE》 *
孔令琳: "鸡原始生殖细胞体外长期培养与建系初探", 《中国畜牧兽医学会家禽学分会第十八次全国家禽学术讨论会》 *
常国斌等: "鹌鹑早期原始生殖细胞迁移和聚集规律的研究", 《畜牧兽医学报》 *
李志腾等: "鸡生殖干细胞中Piwi基因的干涉效率", 《中国农业科学》 *
李碧春等: "鸡生殖干细胞研究现状与展望", 《中国家禽》 *
李碧春等: "鸡胚不同发育时期原始生殖细胞的分离方法", 《动物学报》 *
王娟等: "鸡胚胎生殖细胞在鼠胚成纤维细胞饲养层上的生长", 《生物技术通讯》 *
秦洁等: "细胞因子对鸡胚胎原始生殖细胞(EPGCs)增殖的影响", 《中国生物工程杂志》 *
秦洁等: "鸡胚胎原始生殖细胞的体外培养", 《中国兽医学报》 *
秦洁等: "鸡胚胎原始生殖细胞的培养和传代", 《动物学报》 *
肖小等: "第28期鸡胚原始生殖细胞的冷冻保存与体外培养研究", 《西北农林科技大学学报(自然科学版)》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114410572A (en) * 2022-01-24 2022-04-29 成都思澍生物科技有限公司 Method for quickly separating high-purity primordial germ cells from chick embryo blood
CN115088679A (en) * 2022-07-20 2022-09-23 扬州大学 Method for constructing chimera chicken breed conservation by utilizing gonad cells
CN116855444A (en) * 2023-07-06 2023-10-10 扬州大学 Method for establishing chicken primordial germ cell monoclonal cell line

Also Published As

Publication number Publication date
AU2021101223A4 (en) 2021-05-06

Similar Documents

Publication Publication Date Title
AU2021101223A4 (en) METHOD FOR LONG-TERM IN VITRO CULTURE OF CHICKEN PGCs
JP5843775B2 (en) Manipulation of osmolality to differentiate stem cells
Kala et al. In vitro culture and morphological characterization of prepubertal buffalo (Bubalus bubalis) putative spermatogonial stem cell
CN102787092B (en) Culture medium, cell culture kit and cell culture processes
CN102344906B (en) Hair follicle stem cell separation culture method
CN103966159B (en) Human plactnta Subaerial blue green algae and stem cell bank construction process thereof
CN113025565B (en) Establishment of salmon sperm primitive stem cell line and induced differentiation method thereof
CN112251399B (en) Separation method and culture medium for ricefield eel reproductive stem cells
CN104911144B (en) The isolated culture method of one breeder germinal crescent source PGCs
CN105385651B (en) Inductive pluripotent stem cells Induction of committed differentiation is method and the liver cell of liver cell
CN115747140A (en) Method for inducing differentiation of chicken embryonic stem cells to generate primordial germ cells
CN100540659C (en) A kind of method and special culture media thereof of cultivating mouse embryo stem cell
JP5620905B2 (en) Cell death induction method for pluripotent stem cells and differentiated cells other than cardiomyocytes
CN104694462A (en) Method for directionally inducing to differentiate embryonic stem cell into hepatocyte
CN112544613A (en) Pluripotent stem cell cryopreservation liquid, application thereof and cryopreservation method
CN111304156A (en) Induced trophoblast stem cell and preparation method and application thereof
CN103305459A (en) Method for conversion of porcine spermatogonia stem cell into embryonic stem cell-like cell by small molecule induction
CN104140951B (en) A kind of method set up and cultivate people induced multi-potent stem cell
CN115261301B (en) In-vitro induction and culture method for retinal pigment epithelial cells
CN114276984B (en) Method for transdifferentiating female germ stem cells into functional sperm and application
CN102358892A (en) Manufacturing method for embryoid bodies of bovine induced pluripotent stem (iPS) cells
Freed et al. Characteristics of cell lines from haploid and diploid anuran embryos
CN110331162B (en) Aortic dissection specific induced pluripotent stem cell and disease model application
Xiao et al. Establishing a human pancreatic stem cell line and transplanting induced pancreatic islets to reverse experimental diabetes in rats
CN113652393A (en) Method for improving pluripotency of bovine embryonic stem cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200807

RJ01 Rejection of invention patent application after publication